Link H - Search Results

1

European surveillance of infections and risk factors in cancer patients.

Buchheidt D, Hiddemann W, Schiel X, Kremery V, Karthaus M, Donnelly JP, Wilhelm M, Maschmeyer G, Link H, Adam D, Helmerking M. Buchheidt D, et al. Among authors: link h. Eur J Clin Microbiol Infect Dis. 1999 Feb;18(2):161-3. doi: 10.1007/s100960050251. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10219588 No abstract available.

2

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.

Link H, Maschmeyer G, Meyer P, Hiddemann W, Stille W, Helmerking M, Adam D. Link H, et al. Ann Hematol. 1994 Nov;69(5):231-43. doi: 10.1007/BF01700277. Ann Hematol. 1994. PMID: 7948312 Clinical Trial.

3

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study.

Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E, Schmitt J, Adam D. Maschmeyer G, et al. Among authors: link h. Cancer. 1994 May 1;73(9):2296-304. doi: 10.1002/1097-0142(19940501)73:9<2296::aid-cncr2820730910>3.0.co;2-7. Cancer. 1994. PMID: 8168033 Clinical Trial.

4

Management of infections during intensive treatment of hematologic malignancies.

Maschmeyer G, Hiddemann W, Link H, Cornely OA, Buchheidt D, Glass B, Adam D. Maschmeyer G, et al. Among authors: link h. Ann Hematol. 1997 Jul-Aug;75(1-2):9-16. doi: 10.1007/s002770050306. Ann Hematol. 1997. PMID: 9322678 Review.

5

[Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].

Link H, Blumenstengel K, Böhme A, Cornely O, Kellner O, Nowrousian MR, Ostermann H, Schiel X, Wilhelm M. Link H, et al. Dtsch Med Wochenschr. 1999 Apr 9;124 Suppl 1:S3-8. Dtsch Med Wochenschr. 1999. PMID: 10410648 German. No abstract available.

6

A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.

Schiel X, Link H, Maschmeyer G, Glass B, Cornely OA, Buchheidt D, Wilhelm M, Silling G, Helmerking M, Hiddemann W, Ostermann H, Hentrich M. Schiel X, et al. Among authors: link h. Infection. 2006 Jun;34(3):118-26. doi: 10.1007/s15010-006-5113-9. Infection. 2006. PMID: 16804654 Clinical Trial.

7

[Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].

Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E, Schmitt J, Adam D. Maschmeyer G, et al. Among authors: link h. Med Klin (Munich). 1994 Mar 15;89(3):114-23. Med Klin (Munich). 1994. PMID: 8196571 Clinical Trial. German.

8

[Therapy of infections in patients with acute leukemia].

Hiddemann W, Maschmeyer G, Link H, Helmerking M, Adam D. Hiddemann W, et al. Among authors: link h. Med Klin (Munich). 1997 Jul 15;92(7):406-9. doi: 10.1007/BF03042571. Med Klin (Munich). 1997. PMID: 9324625 Review. German.

9

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).

Link H, Böhme A, Cornely OA, Höffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW; Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO); Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Link H, et al. Ann Hematol. 2003 Oct;82 Suppl 2:S105-17. doi: 10.1007/s00277-003-0764-4. Epub 2003 Sep 9. Ann Hematol. 2003. PMID: 13680173

10

Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.

Behre G, Link H, Maschmeyer G, Meyer P, Paaz U, Wilhelm M, Hiddemann W. Behre G, et al. Among authors: link h. Ann Hematol. 1998 Feb;76(2):73-80. doi: 10.1007/s002770050366. Ann Hematol. 1998. PMID: 9540761 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

819 results

Search Page

Filters